These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32101848)

  • 1. [Thrombolytic recombinant tissue plasminogen activator (rt-PA) treatment in the acute ischemic stroke with limb arterial embolism; three case reports].
    Murao A; Endo T; Nisii T; Tamari Y; Tamai H; Terao S
    Rinsho Shinkeigaku; 2020 Mar; 60(3):223-228. PubMed ID: 32101848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can catheter-directed thrombolysis be applied to acute lower extremity artery embolism after recent cerebral embolism from atrial fibrillation?
    Si TG; Guo Z; Hao XS
    Clin Radiol; 2008 Oct; 63(10):1136-41. PubMed ID: 18774361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic venous thrombolysis with rt-PA in arterial embolism of the legs in the elderly].
    Marci M; Panzini E; Lozzi A; Russo F
    Clin Ter; 1996; 147(7-8):371-6. PubMed ID: 9118619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early intravenous thrombolysis with recombinant tissue plasminogen activator for acute cerebral infarction].
    Wang SY; Wang XL; Zeng H; Zuo Y; Hu N; Li XY; Huang F; Yu HL; Wang HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):542-5. PubMed ID: 12971850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061).
    Hara T; Iwamoto M; Ogawa H; Yamamoto A; Tomikawa M
    Thromb Res; 1990 Aug; 59(4):703-12. PubMed ID: 2127865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preprocedure Intravenous Recombinant Tissue Plasminogen Activator and Risk of Distal Embolization with Thrombectomy in Acute Ischemic Stroke.
    Qureshi AI; Asif A; Aytac E; Liaqat J; Gurkas E; Lobanova I; Saeed O; Ahsan H; Siddiq F; Gomez CR; French BR
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104362. PubMed ID: 31562039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and in-hospital outcomes of recombinant tissue plasminogen activator in pediatric arterial ischemic stroke patients.
    Nasr DM; Biller J; Rabinstein AA
    Pediatr Neurol; 2014 Nov; 51(5):624-31. PubMed ID: 25194722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First case of ischemic stroke which happened during continuous intravenous infusion of rt-PA.
    Zurawska A; Czeczotka J; Rozniecki JJ
    Neurol Neurochir Pol; 2017; 51(3):263-265. PubMed ID: 28400063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.
    Kleindorfer D; Lindsell CJ; Brass L; Koroshetz W; Broderick JP
    Stroke; 2008 Mar; 39(3):924-8. PubMed ID: 18239184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.
    Ueda T; Hatakeyama T; Kumon Y; Sakaki S; Uraoka T
    Stroke; 1994 Feb; 25(2):298-303. PubMed ID: 8303735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety Evaluation on Arterial Thrombolysis in Treating Acute Cerebral Infarction.
    Shen B; Liu Q; Gu Y; Wang Y; Zhang Z
    Cell Biochem Biophys; 2015 Nov; 73(2):297-304. PubMed ID: 27352315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
    Vandelli L; Marietta M; Trenti T; Varani M; Bigliardi G; Rosafio F; Dell'acqua ML; Picchetto L; Nichelli P; Zini A
    Adv Clin Exp Med; 2019 Feb; 28(2):219-222. PubMed ID: 30507073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
    Awadh M; MacDougall N; Santosh C; Teasdale E; Baird T; Muir KW
    Stroke; 2010 Sep; 41(9):1990-5. PubMed ID: 20705933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma let-7i and miR-15a expression are associated with the effect of recombinant tissue plasminogen activator treatment in acute ischemic stroke patients.
    Xiang W; Tian C; Lin J; Wu X; Pang G; Zhou L; Pan S; Deng Z
    Thromb Res; 2017 Oct; 158():121-125. PubMed ID: 28892656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
    Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
    Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.